Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: MisterElbows who wrote (13734)	10/8/2004 3:46:49 PM
From: axial	Respond to of 14101

MisterElbows, welcome to the thread. Been reading you on SH for years. You said, "In light of this, is it no doubt that J&J now wants to talk deal again with Dimethaid?" Good point. Exactly. Equally important, apparently players like JnJ and Solvay (who, just like Provalis, apparently got tired of The Markham Gang's "business prectices) have someone they can trust, to deal with. One gets the impression that The Markham Gang's business acumen, and reputation for fair dealing had become highly suspect. Pennsaid deals appear to be "on". JnJ would be a logical partner for a Pennsaid/Penecure deal - as would Solvay. As you point out, the risks in other products - discussed on Dimethaid threads for years - are now becoming clear. Pennsaid is becoming increasingly attractive. Cheers, Jim